Immuneering Corporation
IMRX
$5.63
-$0.29-4.90%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -62.13M | -61.77M | -61.04M | -58.07M | -56.07M |
| Total Depreciation and Amortization | 374.10K | 380.10K | 385.00K | 388.70K | 378.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.83M | 6.95M | 6.58M | 6.15M | 5.74M |
| Change in Net Operating Assets | 3.42M | 856.20K | -925.40K | -733.50K | -870.60K |
| Cash from Operations | -51.51M | -53.59M | -55.00M | -52.26M | -50.82M |
| Capital Expenditure | -25.70K | -56.40K | -85.00K | -246.50K | -298.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 89.80K | 5.09M | 26.52M | 24.32M | 5.82M |
| Cash from Investing | 64.20K | 5.03M | 26.43M | 24.08M | 5.52M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 18.26M | 18.26M | 5.43M | 5.35M | 1.01M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -191.40K | -127.40K | -127.40K | 0.00 | 0.00 |
| Cash from Financing | 18.07M | 18.13M | 5.30M | 5.35M | 1.01M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -33.37M | -30.42M | -23.26M | -22.83M | -44.29M |